• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过对表皮生长因子受体胞外域进行有限蛋白酶解产生的40千道尔顿表皮生长因子/转化生长因子α结合结构域。

A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.

作者信息

Kohda D, Odaka M, Lax I, Kawasaki H, Suzuki K, Ullrich A, Schlessinger J, Inagaki F

机构信息

Department of Molecular Physiology, Tokyo Metropolitan Institute of Medical Science, Japan.

出版信息

J Biol Chem. 1993 Jan 25;268(3):1976-81.

PMID:8420971
Abstract

Elucidation of the three-dimensional structure of the complex of the epidermal growth factor (EGF) and its receptor is essential for understanding the molecular mechanisms of the EGF-receptor interaction and EGF-induced receptor-receptor interaction. NMR is useful to investigate interactions in solution between macromolecules at atomic resolution, but has a limitation in molecular masses of target proteins: less than 300 residues. We have prepared a fragment with apparent molecular mass of 40 kDa in SDS gels from the soluble extracellular domain of the EGF receptor (sEGFR, 619 residues) by sequential limited proteolysis with proteinase K and bromelain. This fragment is a monomeric structural domain consisting of 202 amino acid residues (Cys302-Arg503) and 18-kDa sugar chains, and binds EGF and transforming growth factor-alpha (TGF alpha). This 40-kDa domain has a dissociation constant of about 1 microM for human TGF alpha, which is similar to that of the parental sEGFR. sEGFR oligomerizes in response to EGF and TGF alpha, while the 40-kDa domain does not, suggesting that the sequences other than this domain is required for receptor oligomerization. The 40-kDa ligand-binding domain described in this report is suitable for analysis by various physico-chemical approaches such as NMR.

摘要

阐明表皮生长因子(EGF)及其受体复合物的三维结构对于理解EGF-受体相互作用和EGF诱导的受体-受体相互作用的分子机制至关重要。核磁共振(NMR)有助于在原子分辨率下研究溶液中大分子之间的相互作用,但对目标蛋白质的分子量有限制:小于300个残基。我们通过用蛋白酶K和菠萝蛋白酶进行顺序有限蛋白水解,从EGF受体(sEGFR,619个残基)的可溶性细胞外结构域制备了在SDS凝胶中表观分子量为40 kDa的片段。该片段是由202个氨基酸残基(Cys302-Arg503)和18 kDa糖链组成的单体结构域,可结合EGF和转化生长因子-α(TGFα)。这个40 kDa的结构域与人TGFα的解离常数约为1 microM,与亲本sEGFR相似。sEGFR会响应EGF和TGFα而发生寡聚化,而40 kDa的结构域则不会,这表明该结构域以外的序列是受体寡聚化所必需的。本报告中描述的40 kDa配体结合结构域适用于通过各种物理化学方法(如NMR)进行分析。

相似文献

1
A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.一种通过对表皮生长因子受体胞外域进行有限蛋白酶解产生的40千道尔顿表皮生长因子/转化生长因子α结合结构域。
J Biol Chem. 1993 Jan 25;268(3):1976-81.
2
The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.表皮生长因子受体的细胞外结构域。结合亲和力与化学计量学、受体二聚化及结合结构域突变体的研究
Eur J Biochem. 1994 Oct 1;225(1):223-33. doi: 10.1111/j.1432-1033.1994.00223.x.
3
Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor.表皮生长因子(EGF)与EGF受体细胞外结构域相互作用的化学计量学、动力学及结合分析。
Growth Factors. 2000;18(1):11-29. doi: 10.3109/08977190009003231.
4
A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.一种变异的表皮生长因子受体表现出α型转化生长因子结合和跨膜信号传导的改变。
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10217-21. doi: 10.1073/pnas.91.21.10217.
5
Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.对表皮生长因子(EGF)与可溶性表皮生长因子受体单体和二聚体结合动力学的实时测量支持了受体激活的二聚化模型。
Biochemistry. 1993 Aug 17;32(32):8193-8. doi: 10.1021/bi00083a020.
6
Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.配体结合增强了表皮生长因子受体细胞外结构域二聚化的亲和力。
J Biochem. 1997 Jul;122(1):116-21. doi: 10.1093/oxfordjournals.jbchem.a021718.
7
Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.利用截短的、高亲和力形式的胞外结构域鉴定表皮生长因子受体配体结合特异性的决定因素。
Biochemistry. 2001 Jul 31;40(30):8930-9. doi: 10.1021/bi010037b.
8
Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor.与人表皮生长因子共价交联的人表皮生长因子受体残基。
Proc Natl Acad Sci U S A. 1990 Apr;87(8):3151-5. doi: 10.1073/pnas.87.8.3151.
9
Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain.表皮生长因子(EGF)可诱导表皮生长因子受体可溶性细胞外配体结合结构域发生寡聚化。配体结合结构域的低分辨率投影结构。
J Biol Chem. 1991 Jul 25;266(21):13828-33.
10
Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.转化生长因子α B环β折叠对表皮生长因子受体结合与激活的作用。
J Biol Chem. 1995 Jan 27;270(4):1612-6.

引用本文的文献

1
Engineered Proteins and Chemical Tools to Probe the Cell Surface Proteome.用于探测细胞表面蛋白质组的工程蛋白和化学工具
Chem Rev. 2025 Apr 23;125(8):4069-4110. doi: 10.1021/acs.chemrev.4c00554. Epub 2025 Apr 3.
2
Structural insights into the role and targeting of EGFRvIII.EGFRvIII 的作用和靶向的结构见解。
Structure. 2024 Sep 5;32(9):1367-1380.e6. doi: 10.1016/j.str.2024.05.018. Epub 2024 Jun 21.
3
Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.胰岛素和表皮生长因子受体家族成员具有平行的激活机制。
Protein Sci. 2020 Jun;29(6):1331-1344. doi: 10.1002/pro.3871. Epub 2020 Apr 28.
4
N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes.N-糖基化作为膜中表皮生长因子受体构象的决定因素。
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4334-9. doi: 10.1073/pnas.1503262112. Epub 2015 Mar 24.
5
Reversion of the ErbB malignant phenotype and the DNA damage response.逆转 ErbB 恶性表型和 DNA 损伤反应。
Exp Mol Pathol. 2012 Dec;93(3):324-33. doi: 10.1016/j.yexmp.2012.09.007. Epub 2012 Sep 27.
6
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.美妥珠单抗与表皮生长因子受体(EGFR)的结合可阻止二聚化所需的构象重排。
Cancer Cell. 2008 Apr;13(4):365-73. doi: 10.1016/j.ccr.2008.02.019.
7
HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks.HER2疗法。HER2(ERBB2):结构保守组件的功能多样性。
Breast Cancer Res. 2007;9(1):202. doi: 10.1186/bcr1633.
8
Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.Muc4与ErbB2在极化的Caco-2上皮细胞中的复合物形成及信号传导表明,Muc4作为ErbB2的非传统配体发挥作用。
Mol Biol Cell. 2006 Jul;17(7):2931-41. doi: 10.1091/mbc.e05-09-0895. Epub 2006 Apr 19.
9
A structure-based model for ligand binding and dimerization of EGF receptors.一种基于结构的表皮生长因子受体配体结合与二聚化模型。
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):929-34. doi: 10.1073/pnas.0307285101. Epub 2004 Jan 19.
10
The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules.胰岛素和表皮生长因子受体的L1和L2结构域与富含亮氨酸重复模块之间的关系。
BMC Bioinformatics. 2001;2:4. doi: 10.1186/1471-2105-2-4. Epub 2001 Jul 27.